Characterization of a Bispecific FLT3 X CD3 Antibody in an Improved, Recombinant Format for the Treatment of Leukemia

Durben, Michael; Schmiedel, Dominik; Hofmann, Martin; Vogt, Fabian; Nuebling, Tina; Pyz, Elwira; Buehring, Hans-Joerg; Rammensee, Hans-Georg; Salih, Helmut R.; Grosse-Hovest, Ludger; Jung, Gundram

dc.contributor.author	Durben, Michael
dc.contributor.author	Schmiedel, Dominik
dc.contributor.author	Hofmann, Martin Florian
dc.contributor.author	Vogt, Fabian
dc.contributor.author	Pyz, Elwira
dc.contributor.author	Rammensee, Hans-Georg
dc.contributor.author	Große-Hovest, Ludger
dc.contributor.author	Jung, Gundram
dc.contributor.author	Nübling, Tina
dc.contributor.author	Bühring, Hans-Jörg
dc.contributor.author	Salih, Helmut R.
dc.date.accessioned	2015-11-11T09:26:49Z
dc.date.available	2015-11-11T09:26:49Z
dc.date.issued	2015
dc.identifier.issn	1525-0016
dc.identifier.uri	http://hdl.handle.net/10900/66345
dc.language.iso	en	en
dc.publisher	Nature Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/mt.2015.2	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Characterization of a Bispecific FLT3 X CD3 Antibody in an Improved, Recombinant Format for the Treatment of Leukemia	de_DE
dc.type	Article	de_DE
utue.quellen.id	20150901145020_01123
utue.publikation.seiten	648-655	de_DE
utue.personen.roh	Durben, Michael
utue.personen.roh	Schmiedel, Dominik
utue.personen.roh	Hofmann, Martin
utue.personen.roh	Vogt, Fabian
utue.personen.roh	Nuebling, Tina
utue.personen.roh	Pyz, Elwira
utue.personen.roh	Buehring, Hans-Joerg
utue.personen.roh	Rammensee, Hans-Georg
utue.personen.roh	Salih, Helmut R.
utue.personen.roh	Grosse-Hovest, Ludger
utue.personen.roh	Jung, Gundram
dcterms.isPartOf.ZSTitelID	Molecular Therapy	de_DE
dcterms.isPartOf.ZS-Issue	4	de_DE
dcterms.isPartOf.ZS-Volume	23	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE